# In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects

> **NCT05569928** · NA · UNKNOWN · sponsor: **Marcello Arca** · enrollment: 20 (estimated)

## Conditions studied

- Familial Hypobetalipoproteinemia
- Familial Hypobetalipoproteinemia - Heterozygous Form

## Interventions

- **OTHER:** Administration of deuterated compounds for kinetic study

## Key facts

- **NCT ID:** NCT05569928
- **Lead sponsor:** Marcello Arca
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-30
- **Primary completion:** 2023-09-30
- **Final completion:** 2025-01-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05569928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05569928, "In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05569928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*